CD44 and invasive breast carcinoma: TRA2B showed the lowest prediction error over all subtypes and had previously been shown to be specifically induced in breast cancer, and more induced in invasive breast cancers compared to non-invasive breast cancers, perhaps by splicing CD44 isoforms [41].